Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Inozyme Pharma (INZY)

Annual Return

Over the past 3 years, INZY has had an average annual return of -10.06%, underperforming the benchmark SPY, which returned +18.49% annual.

Over the past 5 years, INZY has had an average annual return of -30.97%, underperforming the benchmark SPY, which returned +10.57% annual.

Since Jul 24, 2020, INZY has had an average annual return of -25.86%, underperforming the benchmark SPY, which returned +15.85% annual.

202520242023202220212020
+44.46%-34.99%+305.51%-84.59%-66.96%+17.67%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2025-48.01%-16.69%-24.12%+26.40%+244.97%+0.80%+0%+44.46%
2024+29.11%+15.62%+20.44%-42.43%+9.31%-7.46%+30.04%-4.51%-5.57%-17.97%-36.84%+2.20%-34.99%
2023+130.38%+16.88%+102.54%-3.86%+8.72%-7.00%-8.44%-3.92%-14.28%-29.31%+29.65%+10.66%+305.51%
2022-2.06%-13.60%-29.12%-3.43%-6.57%+29.23%-22.62%-18.73%-10.64%-34.36%-17.55%-27.57%-84.59%
2021+1.94%-4.94%-1.01%-6.66%-11.47%+4.16%-1.59%-8.05%-24.83%-19.42%-14.99%-14.12%-66.96%
2020+11.46%+53.35%-12.30%-12.63%+13.28%-20.68%+17.67%

Drawdown analysis of Inozyme Pharma (INZY)

The maximum drawdown for the INZY was -97.28%, occurring on Apr 4, 2025. This drawdown has not yet recovered.

The current INZY drawdown is -86.75%.

Since Jul 24, 2020 INZY has experienced the following drawdowns:

  • 50% or more: 1 time
  • 40% or more: 1 time
  • 30% or more: 1 time
  • 20% or more: 1 time
  • 10% or more: 1 time
DepthStartTo BottomBottomTo RecoverEndTotal
-97.28%Sep 1, 20201153Apr 4, 2025OngoingOngoingOngoing
-9.38%Aug 4, 20203Aug 7, 20202Aug 11, 20205
-4.38%Aug 17, 20206Aug 25, 20204Aug 31, 202010
-2.55%Aug 12, 20202Aug 14, 20201Aug 17, 20203
-1.66%Jul 30, 20201Jul 31, 20201Aug 3, 20202
-1.31%Jul 27, 20201Jul 28, 20201Jul 29, 20202